Most healthcare providers developing an enterprise imaging strategy are considering a vendor-neutral archive or a PACS enterprise archive solution, KLAS found.
Most healthcare providers developing an enterprise imaging strategy are considering a vendor-neutral archive or a PACS enterprise archive solution, according to a new KLAS report.
The report, Enterprise Imaging 2012: Provider’s Strategies and Insights, found that most providers are in the early stages of forming the strategy that would allow access to images at the right time and place, according to market research firm KLAS.
"Image storage is a necessity, no matter what option is chosen," said Ben Brown, imaging research director and author of the report. "As providers start to bring in more studies and the studies themselves increase in size, the need for storage will increase. In addition, as a provider explained, images will need to be managed as well as stored."
Of the providers interviewed, 27 percent said that a vendor-neutral archive (VNA) would be central to their strategy. This option was selected most often by hospitals with more than 500 beds. A PACS-centric archive solution was selected by 25 percent of providers, most of them facilities with fewer than 500 beds.
GE and Philips were mentioned most often by those interviewed, and customers said they considered their vendor to be part of the imaging strategy moving forward, particularly for a PACS-centric approach. Fuji also has a strong PACS enterprise archive offering, according to KLAS. Agfa and Merge were most often cited for VNA approaches.
Provider Reported Enterprise Imaging Strategy:
chart credit: KLAS
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.